Adamas Pharmaceuticals

Adamas is a specialty pharmaceutical company driven to improve the lives of those affected by chronic disorders of the central nervous system (CNS). We achieve this by enhancing the pharmacokinetic profiles of approved drugs to create novel therapeutics for use alone and in fixed-dose combination products.
Type
Public
HQ
Emeryville, US
Founded
2002
Employees
62 (est)+32%
Adamas Pharmaceuticals was founded in 2002 and is headquartered in Emeryville, US

Key People at Adamas Pharmaceuticals

Gopi Kurse

Gopi Kurse

VP of Quality Assurance
Mary Jean Stempien

Mary Jean Stempien

VP, Clinical Research
David Chernoff

David Chernoff

Chief Medical Officer
David Mahoney

David Mahoney

Director
Anthony M. Rimac

Anthony M. Rimac

Chief Financial Officer & SVP Corporate Development
William Dawson

William Dawson

CFO

Adamas Pharmaceuticals Locations

Emeryville, US

Adamas Pharmaceuticals Metrics

Adamas Pharmaceuticals Summary

Market capitalization

$342 M

Closing share price

$15.5
Adamas Pharmaceuticals's latest market capitalization is $342 M.

Adamas Pharmaceuticals Market Value History

32% of current employees of Adamas Pharmaceuticals are female and 68% are male.

Adamas Pharmaceuticals News

Adamas Pharmaceuticals Company Life

You may also be interested in